A citation-based method for searching scientific literature

Hildur Helgadottir, Rainer Tuominen, Håkan Olsson, Johan Hansson, Veronica Höiom. J Am Acad Dermatol 2017
Times Cited: 21







List of co-cited articles
117 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
Jedd D Wolchok, Vanna Chiarion-Sileni, Rene Gonzalez, Piotr Rutkowski, Jean-Jacques Grob, C Lance Cowey, Christopher D Lao, John Wagstaff, Dirk Schadendorf, Pier F Ferrucci,[...]. N Engl J Med 2017
23

Melanoma genetics.
Jazlyn Read, Karin A W Wadt, Nicholas K Hayward. J Med Genet 2016
110
23

Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup.
William Bruno, Lorenza Pastorino, Paola Ghiorzo, Virginia Andreotti, Claudia Martinuzzi, Chiara Menin, Lisa Elefanti, Camilla Stagni, Antonella Vecchiato, Monica Rodolfo,[...]. J Am Acad Dermatol 2016
23
23

High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families.
Hildur Helgadottir, Veronica Höiom, Göran Jönsson, Rainer Tuominen, Christian Ingvar, Ake Borg, Håkan Olsson, Johan Hansson. J Med Genet 2014
48
23

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
19

Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.
Alisa M Goldstein, May Chan, Mark Harland, Nicholas K Hayward, Florence Demenais, D Timothy Bishop, Esther Azizi, Wilma Bergman, Giovanna Bianchi-Scarra, William Bruno,[...]. J Med Genet 2007
257
19

Identification, genetic testing, and management of hereditary melanoma.
Sancy A Leachman, Olivia M Lucero, Jone E Sampson, Pamela Cassidy, William Bruno, Paola Queirolo, Paola Ghiorzo. Cancer Metastasis Rev 2017
49
19

High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.
Alisa M Goldstein, May Chan, Mark Harland, Elizabeth M Gillanders, Nicholas K Hayward, Marie-Francoise Avril, Esther Azizi, Giovanna Bianchi-Scarra, D Timothy Bishop, Brigitte Bressac-de Paillerets,[...]. Cancer Res 2006
273
19

POT1 loss-of-function variants predispose to familial melanoma.
Carla Daniela Robles-Espinoza, Mark Harland, Andrew J Ramsay, Lauren G Aoude, Víctor Quesada, Zhihao Ding, Karen A Pooley, Antonia L Pritchard, Jessamy C Tiffen, Mia Petljak,[...]. Nat Genet 2014
217
19

Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
Jasper I van der Rhee, Pieta Krijnen, Nelleke A Gruis, Femke A de Snoo, Hans F A Vasen, Hein Putter, Nicole A Kukutsch, Wilma Bergman. J Am Acad Dermatol 2011
28
19

Geographical variation in the penetrance of CDKN2A mutations for melanoma.
D Timothy Bishop, Florence Demenais, Alisa M Goldstein, Wilma Bergman, Julia Newton Bishop, Brigitte Bressac-de Paillerets, Agnès Chompret, Paola Ghiorzo, Nelleke Gruis, Johan Hansson,[...]. J Natl Cancer Inst 2002
333
19

Familial melanoma: clinical factors associated with germline CDKN2A mutations according to the number of patients affected by melanoma in a family.
Eve Maubec, Valérie Chaudru, Hamida Mohamdi, Christophe Blondel, Patricia Margaritte-Jeannin, Sébastien Forget, Eve Corda, Françoise Boitier, Stéphane Dalle, Pierre Vabres,[...]. J Am Acad Dermatol 2012
19
21

Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011.
Megan M Moore, Alan C Geller, E Margaret Warton, Joan Schwalbe, Maryam M Asgari. J Am Acad Dermatol 2015
30
19

Germline CDKN2A Mutation Status and Survival in Familial Melanoma Cases.
Hildur Helgadottir, Veronica Höiom, Rainer Tuominen, Kari Nielsen, Göran Jönsson, Håkan Olsson, Johan Hansson. J Natl Cancer Inst 2016
26
19

Clinicopathological features of and risk factors for multiple primary melanomas.
Cristina R Ferrone, Leah Ben Porat, Katherine S Panageas, Marianne Berwick, Allan C Halpern, Ami Patel, Daniel G Coit. JAMA 2005
133
19

Germline mutations in BAP1 predispose to melanocytic tumors.
Thomas Wiesner, Anna C Obenauf, Rajmohan Murali, Isabella Fried, Klaus G Griewank, Peter Ulz, Christian Windpassinger, Werner Wackernagel, Shea Loy, Ingrid Wolf,[...]. Nat Genet 2011
452
14

Cost-Effectiveness of Skin Surveillance Through a Specialized Clinic for Patients at High Risk of Melanoma.
Caroline G Watts, Anne E Cust, Scott W Menzies, Graham J Mann, Rachael L Morton. J Clin Oncol 2017
38
14

Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families.
Femke A de Snoo, D Timothy Bishop, Wilma Bergman, Inge van Leeuwen, Clasine van der Drift, Frans A van Nieuwpoort, Coby J Out-Luiting, Hans F Vasen, Jeanet A C ter Huurne, Rune R Frants,[...]. Clin Cancer Res 2008
116
14

Selection criteria for genetic assessment of patients with familial melanoma.
Sancy A Leachman, John Carucci, Wendy Kohlmann, Kimberly C Banks, Maryam M Asgari, Wilma Bergman, Giovanna Bianchi-Scarrà, Teresa Brentnall, Brigitte Bressac-de Paillerets, William Bruno,[...]. J Am Acad Dermatol 2009
106
14

CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.
Hildur Helgadottir, Veronica Höiom, Rainer Tuominen, Göran Jönsson, Eva Månsson-Brahme, Håkan Olsson, Johan Hansson. Int J Cancer 2015
10
30

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
Corine Bertolotto, Fabienne Lesueur, Sandy Giuliano, Thomas Strub, Mahaut de Lichy, Karine Bille, Philippe Dessen, Benoit d'Hayer, Hamida Mohamdi, Audrey Remenieras,[...]. Nature 2011
324
14

Ten-Year Survival after Multiple Invasive Melanomas Is Worse than after a Single Melanoma: a Population-Based Study.
Danny R Youlden, Peter D Baade, H Peter Soyer, Philippa H Youl, Michael G Kimlin, Joanne F Aitken, Adele C Green, Kiarash Khosrotehrani. J Invest Dermatol 2016
31
14

Multiple primary melanoma: incidence and risk factors in 283 patients.
C L Slingluff, R T Vollmer, H F Seigler. Surgery 1993
79
14

Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Jeffrey E Gershenwald, Richard A Scolyer, Kenneth R Hess, Vernon K Sondak, Georgina V Long, Merrick I Ross, Alexander J Lazar, Mark B Faries, John M Kirkwood, Grant A McArthur,[...]. CA Cancer J Clin 2017
887
14

Enhanced survival in patients with multiple primary melanoma.
Anna Doubrovsky, Scott W Menzies. Arch Dermatol 2003
55
14

Survival outcomes in patients with multiple primary melanomas.
C J Rowe, M H Law, J M Palmer, S MacGregor, N K Hayward, K Khosrotehrani. J Eur Acad Dermatol Venereol 2015
17
17

Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study.
Fergal J Moloney, Pascale Guitera, Elliot Coates, Nikolas K Haass, Kenneth Ho, Ritta Khoury, Rachel L O'Connell, Leo Raudonikis, Helen Schmid, Graham J Mann,[...]. JAMA Dermatol 2014
73
14

Multiple primary melanomas.
T M Johnson, T Hamilton, L Lowe. J Am Acad Dermatol 1998
69
14

Update in genetic susceptibility in melanoma.
Miriam Potrony, Celia Badenas, Paula Aguilera, Joan Anton Puig-Butille, Cristina Carrera, Josep Malvehy, Susana Puig. Ann Transl Med 2015
89
14

Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
Jianxin Shi, Xiaohong R Yang, Bari Ballew, Melissa Rotunno, Donato Calista, Maria Concetta Fargnoli, Paola Ghiorzo, Brigitte Bressac-de Paillerets, Eduardo Nagore, Marie Francoise Avril,[...]. Nat Genet 2014
198
14

Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.
Lauren G Aoude, Antonia L Pritchard, Carla Daniela Robles-Espinoza, Karin Wadt, Mark Harland, Jiyeon Choi, Michael Gartside, Víctor Quesada, Peter Johansson, Jane M Palmer,[...]. J Natl Cancer Inst 2014
100
14

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma.
L Zuo, J Weger, Q Yang, A M Goldstein, M A Tucker, G J Walker, N Hayward, N C Dracopoli. Nat Genet 1996
609
14

Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non-CDKN2A/CDK4 melanoma families.
Thomas P Potjer, Sander Bollen, Anneliese J E M Grimbergen, Remco van Doorn, Nelleke A Gruis, Christi J van Asperen, Frederik J Hes, Nienke van der Stoep. Int J Cancer 2019
24
14

Role of the CDKN2A locus in patients with multiple primary melanomas.
Susana Puig, Josep Malvehy, Cèlia Badenas, Anna Ruiz, Dolores Jimenez, Francisco Cuellar, Antoni Azon, Urbá Gonzàlez, Teresa Castel, Antoni Campoy,[...]. J Clin Oncol 2005
106
14


Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
9

Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib.
Georgina V Long, Zeynep Eroglu, Jeffrey Infante, Sapna Patel, Adil Daud, Douglas B Johnson, Rene Gonzalez, Richard Kefford, Omid Hamid, Lynn Schuchter,[...]. J Clin Oncol 2018
123
9


Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial.
Paolo A Ascierto, Grant A McArthur, Brigitte Dréno, Victoria Atkinson, Gabrielle Liszkay, Anna Maria Di Giacomo, Mario Mandalà, Lev Demidov, Daniil Stroyakovskiy, Luc Thomas,[...]. Lancet Oncol 2016
491
9

Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial.
Michael A Davies, Philippe Saiag, Caroline Robert, Jean-Jacques Grob, Keith T Flaherty, Ana Arance, Vanna Chiarion-Sileni, Luc Thomas, Thierry Lesimple, Laurent Mortier,[...]. Lancet Oncol 2017
297
9


Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial.
Paolo A Ascierto, Michele Del Vecchio, Caroline Robert, Andrzej Mackiewicz, Vanna Chiarion-Sileni, Ana Arance, Céleste Lebbé, Lars Bastholt, Omid Hamid, Piotr Rutkowski,[...]. Lancet Oncol 2017
254
9

The Genetic Evolution of Melanoma from Precursor Lesions.
A Hunter Shain, Iwei Yeh, Ivanka Kovalyshyn, Aravindhan Sriharan, Eric Talevich, Alexander Gagnon, Reinhard Dummer, Jeffrey North, Laura Pincus, Beth Ruben,[...]. N Engl J Med 2015
492
9

The melanocyte lineage in development and disease.
Richard L Mort, Ian J Jackson, E Elizabeth Patton. Development 2015
135
9

Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.
Mohamed H Abdel-Rahman, Robert Pilarski, Colleen M Cebulla, James B Massengill, Benjamin N Christopher, Getachew Boru, Peter Hovland, Frederick H Davidorf. J Med Genet 2011
293
9

Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial.
Reinhard Dummer, Dirk Schadendorf, Paolo A Ascierto, Ana Arance, Caroline Dutriaux, Anna Maria Di Giacomo, Piotr Rutkowski, Michele Del Vecchio, Ralf Gutzmer, Mario Mandala,[...]. Lancet Oncol 2017
199
9

A landscape of driver mutations in melanoma.
Eran Hodis, Ian R Watson, Gregory V Kryukov, Stefan T Arold, Marcin Imielinski, Jean-Philippe Theurillat, Elizabeth Nickerson, Daniel Auclair, Liren Li, Chelsea Place,[...]. Cell 2012
9

Elucidating distinct roles for NF1 in melanomagenesis.
Ophélia Maertens, Bryan Johnson, Pablo Hollstein, Dennie T Frederick, Zachary A Cooper, Ludwine Messiaen, Roderick T Bronson, Martin McMahon, Scott Granter, Keith Flaherty,[...]. Cancer Discov 2013
155
9

Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF.
C Mangas, M Potrony, C Mainetti, E Bianchi, P Carrozza Merlani, A Mancarella Eberhardt, E Maspoli-Postizzi, G Marazza, A Marcollo-Pini, F Pelloni,[...]. Br J Dermatol 2016
11
18

Whole-genome landscapes of major melanoma subtypes.
Nicholas K Hayward, James S Wilmott, Nicola Waddell, Peter A Johansson, Matthew A Field, Katia Nones, Ann-Marie Patch, Hojabr Kakavand, Ludmil B Alexandrov, Hazel Burke,[...]. Nature 2017
549
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.